Robert E Coleman

Title: The Innovations of Robert E. Coleman

Introduction

Robert E. Coleman is a notable inventor based in Sheffield, GB. He has made significant contributions to the field of medical treatments, particularly in the area of breast cancer therapy. With a total of 3 patents to his name, Coleman's work focuses on innovative approaches to customize therapies based on individual patient needs.

Latest Patents

One of Coleman's latest patents is centered on the therapeutic treatment of breast cancer based on c-MAF status. This invention relates to designing a customized therapy for subjects with breast cancer, taking into account the c-MAF expression level and the menopausal status of the subject. In some embodiments, the customized therapy includes an agent for avoiding, treating, or preventing bone degradation. Specifically, the agent may be zoledronic acid, clodronate, or denosumab. This innovative approach aims to enhance treatment efficacy and improve patient outcomes.

Career Highlights

Coleman is currently associated with Inbiomotion S.L., where he continues to develop groundbreaking therapies. His work has been instrumental in advancing personalized medicine, particularly in oncology. His dedication to research and innovation has positioned him as a key figure in the medical community.

Collaborations

Throughout his career, Coleman has collaborated with esteemed colleagues, including Walter Martin Gregory and Juan Carlos Tercero. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of innovative solutions in cancer treatment.

Conclusion

Robert E. Coleman exemplifies the spirit of innovation in the medical field, particularly in breast cancer treatment. His contributions through patented inventions reflect a commitment to improving patient care and advancing therapeutic options. His work continues to inspire future developments in personalized medicine.